← Back to Search

FOREST Program for Burnout and Secondary Traumatic Stress (FOREST Trial)

N/A
Waitlist Available
Led By Judith Moskowitz, PhD, MPH
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

FOREST Trial Summary

This trial program helps violence prevention workers build positive emotion skills to reduce burnout and improve resilience in their work. #mentalhealth #resilience

Who is the study for?
The FOREST trial is for frontline violence prevention workers at READI Chicago who are over 18, speak and read English, and have internet access. There are no specific exclusion criteria, so all employees meeting the inclusion conditions can participate.Check my eligibility
What is being tested?
FOREST is a program teaching ten positive emotion skills over nine months to improve mental health and coping among participants. It's integrated into regular meetings, wellness activities, and online modules within READI's Learning Management System.See study design
What are the potential side effects?
Since FOREST is an emotion skills program rather than a medical treatment, it does not have traditional side effects. However, participants may experience emotional discomfort or increased self-awareness as they learn new coping strategies.

FOREST Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Decrease in anxiety measured by PROMIS Short Form v1.0- Anxiety 4a.
Decrease in burnout measured by the Maslach Burnout Inventory (MBI).
Decrease in depression measured by PROMIS Short Form v1.0- Depression 4a.
+5 more
Secondary outcome measures
Decrease in staff turnover.
Decrease in use of sick days
Increase in staff promotion
+1 more

FOREST Trial Design

1Treatment groups
Experimental Treatment
Group I: FOREST + AssessmentsExperimental Treatment1 Intervention
READI staff will participate in Monthly Skill Sessions and complete FOREST content modules in the Learning Management System (LMS). Staff will also be invited to complete annual assessments for primary and secondary outcome measures, as well as annual interviews and focus groups to gather feedback on progress, implementation, and content.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
FOREST
2021
N/A
~210

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,131 Total Patients Enrolled
Judith Moskowitz, PhD, MPHPrincipal InvestigatorNorthwestern University
2 Previous Clinical Trials
161 Total Patients Enrolled

Media Library

FOREST + Assessments Clinical Trial Eligibility Overview. Trial Name: NCT05942469 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What primary aims does this trial endeavor to accomplish?

"This clinical trial intends to measure the reduction in vicarious trauma of participants over a 12 month duration with Secondary Traumatic Stress Scale. Additionally, secondary objectives include ascertaining lower sick day use via employee records, increased staff retention and promotion through corresponding record keeping methods."

Answered by AI

Is there an opportunity for participants to enlist in this clinical investigation?

"Clinicaltrials.gov states that this particular study is no longer recruiting patients, having first been posted on September 17th 2023 and last updated July 11th 2023. However, there are presently 1504 other trials seeking participants across the world."

Answered by AI
~67 spots leftby Sep 2025